Strategic Plan
The Riddell Centre for Cancer Immunotherapy | 2024-2029
Safe, effective, and accessible treatments for cancer patients
Since its creation in fall 2023, the Riddell Centre for Cancer Immunotherapy has collaborated extensively with partners, including researchers, clinicians, stakeholders, and patient advisors, to develop a strategic plan that integrates diverse perspectives and insights on research focus and impact.
Our five-year strategic plan (2024-2029) aims to positions the Riddell Centre as a leader in immunotherapy research through three core pillars of activity: discovery and innovation science to identify and develop new immunotherapy strategies, biomanufacturing to produce complex immune therapies for clinical studies, and clinical research and translation to bring experimental treatments into early‑phase human trials.
If you would like to receive a printed copy of the Riddell Centre Strategic Plan, please email riddellcentre@ucalgary.ca.
